BioNexus Gene Lab
BGLC1.3600.00% ( 0.000 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: BioNexus Gene Lab(BGLC) the Revenue is 22.84 K (-98.93%);the EBIT is -563.29 K (+4.03%);the EPS is -0.225 (+35.18%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B98.93%
----
----
EBIT
-0.00B4.03%
----
----
EPS
-0.224935.18%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf